IB
Infensa Bioscience develops novel pharmaceutical agents aimed at treating acute cardiovascular events. The company focuses on creating drugs to reduce the mortality and morbidity associated with heart attack and stroke. This work addresses the lack of current therapeutic options for these leading causes of death worldwide.
Updated 3 months ago
Funding
$16M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Infensa Bioscience develops novel pharmaceutical agents aimed at treating acute cardiovascular events. The company focuses on creating drugs to reduce the mortality and morbidity associated with heart attack and stroke. This work addresses the lack of current therapeutic options for these leading causes of death worldwide.